Gilead's Remdesivir Shows Mixed Results In Coronavirus Test; Shares Dive

Gilead's Remdesivir Shows Mixed Results In Coronavirus Test; Shares Dive

Early Monday, Gilead Sciences reported mixed results for its coronavirus treatment, remdesivir, in patients moderately ill with Covid-19. As a result, GILD stock dipped.